Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.27% | -59.23% | -43.36% | -51.08% | -19.36% |
| Total Depreciation and Amortization | 529.12% | 373.15% | 227.38% | 114.59% | -17.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -53.85% | -15.56% | -115.42% | 98.94% | 75.08% |
| Change in Net Operating Assets | 323.00% | 274.27% | 373.29% | -375.99% | -42.35% |
| Cash from Operations | 23.93% | 54.94% | 22.17% | -12.50% | 29.29% |
| Capital Expenditure | -49,607.45% | -53,260.00% | -55,486.11% | -- | -98.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -49,607.45% | -53,260.00% | -55,486.11% | -- | -98.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12,465.57% | -146.49% | -109.91% | -101.01% | -19.61% |
| Issuance of Common Stock | -85.56% | -82.83% | -64.32% | 21.09% | 180.37% |
| Repurchase of Common Stock | 60.38% | 100.00% | 96.83% | -691.15% | -562.87% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 536.46% | 840.95% | 849.35% | 7,118.13% | -572.05% |
| Foreign Exchange rate Adjustments | 166.87% | -353.04% | -307.94% | -46.41% | 17.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -414.66% | -333.59% | -300.09% | -322.89% | -4.12% |